ArticleReproductive biology and endocrinology : RB&E2025
Interaction between embryo transfer timing (D3/D4) and duration of progesterone exposure (P3/P4) on live birth rate in hormone replacement therapy cycles of frozen embryo transfer.
Article in Reproductive biology and endocrinology : RB&E, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveIn hormone replacement therapy (HRT) cycles of frozen embryo transfer (FET), progesterone-induced endometrial transformation is critical to clinical outcomes. This study aimed to evaluate the interactive impact of the extent of progesterone exposure and the timing of embryo transfer on live birth outcomes.
methodsThis study retrospectively reviewed 3,381 infertile individuals from June 2013 to June 2024. Participants were stratified into four categories based on the number of days of progesterone exposure (P) and embryo developmental stage at transfer (D): P3-D3 group, P3-D4 group, P4-D3 group, and P4-D4 group.
resultsAnalysis showed comparable baseline characteristics among all groups, with no significant variation. When progesterone exposure duration was synchronized with embryo developmental day, the P4-D4 group exhibited significantly higher live birth rate (47.58% vs 30.41%), clinical pregnancy rate (58.89% vs 44.33%), and implantation rate (41.17% vs 25.07%) in contrast to the P3-D3 cohort (P < 0.001), along with a significantly lower miscarriage rate (17.2% vs 26.7%, P = 0.025). When progesterone exposure duration was held constant, D4 embryo transfer significantly improved live birth rate over D3 embryo transfer (P3-D4 group vs P3-D3 group: 44.72% vs 30.41%, P = 0.005; P4-D4 group vs P4-D3 group: 47.58% vs 30.80%, P < 0.001). When embryo developmental stage at transfer was fixed, outcomes related to pregnancy showed no variation between the three-day and four-day exposure schedules. progesterone exposure (P > 0.05). To systematically examine and identify the independent clinical factors that significantly influence live birth outcomes in a target population, a logistic regression approach was employed to provide a comprehensive understanding of the underlying relationships. Consistent results were observed.
conclusionFrozen embryo transfer cycles prepared with hormone replacement demonstrate higher live birth rates when embryos are transferred on day 4 rather than day 3, regardless of whether progesterone exposure is 3 or 4 days. When embryo developmental stage is fixed (D3 or D4), varying the duration of progesterone exposure (3 vs 4 days) does not significantly influence clinical or perinatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.